Colon Neoplasm Clinical Trial
Official title:
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer: a Prospective Single-center Multi-arm Open-label Randomized Phase II Study
This study aims to elucidate the regression effects of neoadjuvant chemotherapy combined with immunotherapy and adjuvant therapy in locally advanced MSS colon cancer.
The standard treatment for locally advanced colon cancer is surgery followed by adjuvant chemotherapy containing oxaliplatin. The MOSAIC and 16968 studies have shown that approximately 30% of patients experience recurrence and metastasis within 6-7 years after surgery. Neoadjuvant chemotherapy may improve the prognosis of patients with malignant tumors. The significant tumor shrinkage after neoadjuvant therapy indicates a greater likelihood of long-term survival for patients. The OPTICAL and FoxTROT studies have shown that approximately 35% of patients are resistant to oxaliplatin-containing neoadjuvant chemotherapy, with a pCR rate of less than 10% and uncertain survival improvement. In addition, immunotherapy has poor efficacy for microsatellite stable (MSS) patients. Therefore, it is necessary to explore new and effective neoadjuvant treatment modalities for tumor regression. The study will screen for individuals who are sensitive to oxaliplatin-containing regimens through induction chemotherapy. Immunogenic cell death will be enhanced by oxaliplatin-induced immunogenicity and combined with anti-programmed cell death ligand 1 (PD-L1) monoclonal antibodies for neoadjuvant therapy. In the context of cancer, the role of the intestinal microbiome in mediating immune activation induced by chemotherapy drugs has been demonstrated. Clostridium butyricum will be introduced as an adjuvant to explore the possibility of further increasing the significant response rate of neoadjuvant therapy. The study will first conduct 2 cycles of Capox induction chemotherapy to screen for patients sensitive to chemotherapy. Patients will be randomized into three cohorts: one chemotherapy standard control cohort (continuing Capox chemotherapy for 2 cycles) and two enhancement design cohorts (Capox chemotherapy + Anti-PD-L1 monoclonal antibody for 2 cycles/Capox chemotherapy + Anti-PD-L1 monoclonal antibody + Clostridium butyricum for 2 cycles), followed by CME surgery. The study's primary endpoint is the proportion of Tumor regression grade(TRG)0/1 in the pathological specimens of surgically resected tumors. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Terminated |
NCT04555135 -
A Clinical Study To Measure The Effect Of Use Of Artificial Intelligence (AI) Enabled Computer Aided Detection (CADe) Assistance Software In Detecting Colon Polyps During Standard Colonoscopy Procedures
|
N/A | |
Terminated |
NCT00249301 -
A Study of MLN8054 in Patients With Advanced Solid Tumors
|
Phase 1 | |
Active, not recruiting |
NCT05279612 -
Effect Analysis of Neoadjuvant Chemoradiotherapy Combined With Surgery in Laparoscope for Advanced Colon Cancer
|
||
Active, not recruiting |
NCT04369053 -
Prevention of Colorectal Cancer Through Multiomics Blood Testing
|
||
Recruiting |
NCT05411783 -
Low Tie Versus High Tie of the Inferior Mesenteric Vein During Colorectal Cancer Surgery: A Randomized Clinical Trial
|
N/A | |
Recruiting |
NCT05345613 -
Tranexamic Acid During Colonic Endoscopic Resection Procedures
|
Phase 4 | |
Recruiting |
NCT03803891 -
Endoscopic Full-Thickness Resection In Colon
|
||
Completed |
NCT04799080 -
Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function
|
||
Recruiting |
NCT05034692 -
Application of Overlap Method to Digestive Tract Reconstruction of Totally Laparoscopic Left Colectomy
|
N/A | |
Recruiting |
NCT04920149 -
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT00295035 -
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer
|
Phase 3 | |
Recruiting |
NCT03065257 -
Endoscopic Resection Multicenter Registry
|
N/A | |
Recruiting |
NCT03198338 -
Ultrasound Guided Transversus Abdominis Plane(TAP) Block in Intensive Care Unit
|
N/A | |
Completed |
NCT05497726 -
Fluorescent Sentinel Lymph Node Identification in Colon Carcinoma Using Intravenous Bevacizumab-800CW
|
N/A | |
Completed |
NCT03723720 -
Calculating of Correlations Between ADR, PDR, MAP
|
||
Completed |
NCT03730441 -
Correlation Between ADR of Screening and All Colonoscopies
|
||
Recruiting |
NCT05446558 -
Long-term Results in Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Right Colectomy
|
N/A | |
Recruiting |
NCT03458689 -
Quadratus Lumborum Block Versus Transversus Abdominis Plane Block in Patients Undergoing Left Hemicolectomy
|
N/A | |
Completed |
NCT03719573 -
Geriatric Assessment and Intervention in Older Patients Undergoing Surgery for Colorectal Cancer
|
N/A |